FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19588111000001107: Zalasta 7.5mg tablets (Krka UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Nov 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2575171000001112 Zalasta 7.5mg tablets (Krka UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2575181000001114 Zalasta 7.5mg tablets (Krka UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zalasta 7.5mg tablets (Krka UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zalasta 7.5mg tablets (Krka UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zalasta 7.5mg tablets (Krka UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zalasta 7.5mg tablets (Krka UK Ltd) Is a Product containing precisely olanzapine 7.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zalasta 7.5mg tablets (Krka UK Ltd) Has active ingredient Olanzapine false Inferred relationship Existential restriction modifier
Zalasta 7.5mg tablets (Krka UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zalasta 7.5mg tablets (Krka UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zalasta 7.5mg tablets (Krka UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zalasta 7.5mg tablets (Krka UK Ltd) Has specific active ingredient Olanzapine true Inferred relationship Existential restriction modifier
Zalasta 7.5mg tablets (Krka UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zalasta 7.5mg tablets (Krka UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Zalasta 7.5mg tablets (Krka UK Ltd) Is a Zalasta true Inferred relationship Existential restriction modifier
Zalasta 7.5mg tablets (Krka UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zalasta 7.5mg tablets (Krka UK Ltd) 56 tablet 8 x 7 tablets Has AMP True Zalasta 7.5mg tablets (Krka UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start